Thiamphenicol

甲砜霉素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameThiamphenicol
Drug Alias Nametianfenicol甲砜基脱硝氯霉素甲磺氯霉素thiamphenicolum甲砜毒素 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesXinxin Pharmaceutical Factory of Tianjin Zhongxin Pharmaceutical Group Co LtdTianjin Pharmaceutical Peace (Tianjin) Pharmaceutical Co Ltd
Inactive CompaniesPsyadon Pharma
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01BA02
Related LinksWikipediaKEGG